2,819
Views
2
CrossRef citations to date
0
Altmetric
Research Article

Systematic identification of the interventional mechanism of Qingfei Xiaoyan Wan (QFXYW) in treatment of the cytokine storm in acute lung injury using transcriptomics-based system pharmacological analyses

, , , , , , & ORCID Icon show all
Pages 743-754 | Received 15 Sep 2021, Accepted 12 Mar 2022, Published online: 31 Mar 2022

References

  • Arif Y, Singh P, Siddiqui H, Bajguz A, Hayat S. 2020. Salinity induced physiological and biochemical changes in plants: an omic approach towards salt stress tolerance. Plant Physiol Biochem. 156:64–77.
  • Cao Z, Zeng Z, Wang B, Liu C, Liu C, Wang Z, Li S. 2021. Identification of potential bioactive compounds and mechanisms of GegenQinlian decoction on improving insulin resistance in adipose, liver, and muscle tissue by integrating system pharmacology and bioinformatics analysis. J Ethnopharmacol. 264:113289.
  • Cardoso-Sousa L, Aguiar EMG, Caixeta DC, Vilela DD, Costa D. P d, Silva TL, Cunha TM, Faria PR, Espindola FS, Jardim AC, et al. 2019. Effects of salbutamol and phlorizin on acute pulmonary inflammation and disease severity in experimental sepsis. PLOS One. 14(9):e0222575.
  • Chen CM, Tung YT, Wei CH, Lee PY, Chen W. 2020a. Anti-inflammatory and reactive oxygen species suppression through aspirin pretreatment to treat hyperoxia-induced acute lung injury in NF-kappaB-luciferase inducible transgenic mice. Antioxidants. 9(5):429–435.
  • Chen L, Hu C, Hood M, Kan J, Gan X, Zhang X, Zhang Y, Du J. 2020b. An integrated approach exploring the synergistic mechanism of herbal pairs in a botanical dietary supplement: a case study of a liver protection health food. Int J Genomics. 2020(1):9054192.
  • Cheng B, Hou Y, Wang L, Dong L, Peng J, Bai G. 2012. Dual-bioactivity-based liquid chromatography-coupled quadrupole time-of-flight mass spectrometry for NF-κB inhibitors and β2AR agonists identification in Chinese Medicinal Preparation Qingfei Xiaoyan Wan. Anal Bioanal Chem. 404(8):2445–2452.
  • Dai Z, Shu X, Li G, Xi W. 2018. Performance evaluation of protein chip assay for rapid diagnosis of hepatitis C virus infection in injection drug abusers. Clin Lab. 64(4):527–534.
  • Ding Z, Zhong R, Yang Y, Xia T, Wang W, Wang Y, Xing N, Luo Y, Li S, Shang L, et al. 2020. Systems pharmacology reveals the mechanism of activity of Ge-Gen-Qin-Lian decoction against LPS-induced acute lung injury: a novel strategy for exploring active components and effective mechanism of TCM formulae. Pharmacol Res. 156(1):104759.
  • Eves ND, Song Y, Piper A, Maher TM. 2013. Year in review 2012: acute lung injury, interstitial lung diseases, sleep and physiology. Respirology. 18(3):555–564.
  • Fasolino I, Soriente A, Ambrosio L, Raucci MG. 2020. Osteogenic and anti-inflammatory behavior of injectable calcium phosphate loaded with therapeutic drugs. Nanomaterials. 10(9):1743–1715.
  • Ge X, Meng X, Fei D, Kang K, Wang Q, Zhao M. 2020. Lycorine attenuates lipopolysaccharide-induced acute lung injury through the HMGB1/TLRs/NF-κB pathway. 3 Biotech. 10(8):369.
  • Han XZ, Ma R, Chen Q, Jin X, Jin YZ, An RB, Piao XM, Lian ML, Quan LH, Jiang J. 2018. Anti-inflammatory action of Athyrium multidentatum extract suppresses the LPS-induced TLR4 signaling pathway. J Ethnopharmacol. 217:220–227.
  • Hou Y, Cheng B, Zhou M, Fang R, Jiang M, Hou W, Bai G. 2014. Searching for synergistic bronchodilators and novel therapeutic regimens for chronic lung diseases from a traditional Chinese medicine, Qingfei Xiaoyan Wan. PLOS One. 9(11):e113104.
  • Hou Y, Nie Y, Cheng B, Tao J, Ma X, Jiang M, Gao J, Bai G. 2016. Qingfei Xiaoyan Wan, a traditional Chinese medicine formula, ameliorates Pseudomonas aeruginosa-induced acute lung inflammation by regulation of PI3K/AKT and Ras/MAPK pathways. Acta Pharm Sin B. 6(3):212–221.
  • Huang XF, Zhang JL, Huang DP, Huang AS, Huang HT, Liu Q, Liu XH, Liao HL. 2020. A network pharmacology strategy to investigate the anti-inflammatory mechanism of luteolin combined with in vitro transcriptomics and proteomics. Int Immunopharmacol. 86:106727.
  • Hui Y, Wang X, Yu Z, Fan X, Cui B, Zhao T, Mao L, Feng H, Lin L, Yu Q. 2020. Scoparone as a therapeutic drug in liver diseases: pharmacology, pharmacokinetics and molecular mechanisms of action. Pharmacol Res. 12:105170.
  • Jan JS, Yang CH, Wang MH, Lin FL, Yen JL, Hsieh I, Khotimchenko M, Lee TH, Hsiao G. 2019. Hirsutanol A attenuates lipopolysaccharide-mediated matrix metalloproteinase 9 expression and cytokines production and improves endotoxemia-induced acute sickness behavior and acute lung injury. Mar Drugs. 17:360.
  • Kersch CN, Claunch CJ, Ambady P, Bucher E, Schwartz DL, Barajas RF, Iliff JJ, Risom T, Heiser L, Muldoon LL, et al. 2020. Transcriptional signatures in histologic structures within glioblastoma tumors may predict personalized drug sensitivity and survival. Neurooncol Adv. 2(1):vdaa093.
  • Kumar V. 2020. Pulmonary innate immune response determines the outcome of inflammation during pneumonia and sepsis-associated acute lung injury. Front Immunol. 11:1722.
  • Li X, Huang X, Tang Y, Zhao F, Cao Y, Yin L, Li G. 2018. Assessing the pharmacological and therapeutic efficacy of traditional Chinese medicine Liangxue Tongyu prescription for intracerebral hemorrhagic stroke in neurological disease models. Front Pharmacol. 9:1169.
  • Liang J, Bonvino NP, Hung A, Karagiannis TC. 2020. In silico characterisation of olive phenolic compounds as potential cyclooxygenase modulators. Part 1. J Mol Graph Model. 101:107719.
  • Liu TY, Zhao LL, Chen SB, Hou BC, Huang J, Hong X, Qing L, Fang Y, Tao Z. 2020. Polygonatum sibiricum polysaccharides prevent LPS-induced acute lung injury by inhibiting inflammation via the TLR4/Myd88/NF-κB pathway. Exp Ther Med. 20(4):3733–3739.
  • Ma Y, Yang X, Chatterjee V, Wu M, Yuan SY. 2021. The gut-lung axis in systemic inflammation. Role of mesenteric lymph as a conduit. Am J Respir Cell Mol Biol. 64(1):19–28.
  • Nagy Á, Győrffy B. 2021. muTarget: a platform linking gene expression changes and mutation status in solid tumors. Int J Cancer. 148(2):502–511.
  • Nasralla S, Abboud H. 2020. Is neuromyelitis optica without AQP4-IgG a T-cell mediated disease? Insights from checkpoint inhibitor immune-related adverse events. Mult Scler Relat Disord. 46:102451.
  • Ouattara DA, Remolue L, Becker J, Perret M, Bunescu A, Hennig K, Biliaut E, Badin A, Giacomini C, Reynier F, et al. 2020. An integrated transcriptomics and metabolomics study of the immune response of newly hatched chicks to the cytosine-phosphate-guanine oligonucleotide stimulation. Poult Sci. 99(9):4360–4372.
  • Pearce RE, Leeder JS, Kearns GL. 2006. Biotransformation of fluticasone: in vitro characterization. Drug Metab Dispos. 34(6):1035–1040.
  • Peng Y, Wu Q, Tang H, Chen J, Wu Q, Yuan X, Xiong S, Ye Y, Lv H. 2020. NLRP3 regulated CXCL12 expression in acute neutrophilic lung injury. J Inflamm Res. 13:377–386.
  • Persson PB. 2019. Good publication practice in physiology. Acta Physiol. 227(4):212–231.
  • Prasad K, Khatoon F, Rashid S, Ali N, AlAsmari AF, Ahmed MZ, Alqahtani AS, Alqahtani MS, Kumar V. 2020. Targeting hub genes and pathways of innate immune response in COVID-19: a network biology perspective. Int J Biol Macromol. 163:1–8.
  • Racz FS, Stylianou O, Mukli P, Eke A. 2020. Multifractal and entropy-based analysis of delta band neural activity reveals altered functional connectivity dynamics in schizophrenia. Front Syst Neurosci. 14:49.
  • Schilling MK, Eichenberger M, Maurer CA, Sigurdsson G, Buchler MW. 2001. Ketoconazole and pulmonary failure after esophagectomy: a prospective clinical trial. Dis Esophagus. 14(1):37–40.
  • Percie Du Sert N, Hurst V, Ahluwalia A, Alam S, Avey MT, Baker M, Browne WJ, Clark A, Cuthill IC, Dirnagl U, et al. 2020. The ARRIVE guidelines 2.0: updated guidelines for reporting animal research*. J Cereb Blood Flow Metab. 40(9):1769–1777.
  • Sheu SC, Huang JY, Lien YY, Lee MS. 2020. Specific, sensitive and rapid authentication of donkey-hide gelatine (Colla corii asini) in processed food using an isothermal nucleic acid amplification assay. J Food Sci Technol. 57(8):2877–2883.
  • Shockley KR, Cora MC, Malarkey DE, Jackson-Humbles D, Vallant M, Collins BJ, Mutlu E, Robinson VG, Waidyanatha S, Zmarowski A, et al. 2020. Transcriptomic data from the rat liver after five days of exposure to legacy or emerging brominated flame retardants. Data Brief. 32:106136.
  • Shu Z, Wu T, Shahen M, Guo Z, Shu J, Wang HE, Shar AH, Farag MR, Alagawany M, El-Hack MEA, et al. 2019. System-pharmacology dissection of traditional Chinese herbs SINI decoction for treatment of cardiovascular diseases. An Acad Bras Cienc. 91(3):e20180424.
  • Simons RK, Junger WG, Loomis WH, Hoyt DB. 1996. Acute lung injury in endotoxemic rats is associated with sustained circulating IL-6 levels and intrapulmonary CINC activity and neutrophil recruitment–role of circulating TNF-alpha and IL-beta? Shock. 6(1):39–45.
  • Sun J, Ding X, Liu S, Duan X, Liang H, Sun T. 2020. Adipose-derived mesenchymal stem cells attenuate acute lung injury and improve the gut microbiota in septic rats. Stem Cell Res Ther. 11(1):384.
  • Wang F, Wang M, Wang J, Chen M, Sun S, Yao S, Xia H. 2020a. Maresin1 ameliorates sepsis-associated lung injury by inhibiting the activation of the JAK2/STAT3 and MAPK/ NF-κB signaling pathways. Microb Pathog. 148:104468.
  • Wang NA, Su Y, Che XM, Zheng H, Shi ZG. 2016. Penehyclidine ameliorates acute lung injury by inhibiting Toll-like receptor 2/4 expression and nuclear factor-κB activation. Exp Ther Med. 11(5):1827–1832.
  • Xu J, Wang F, Guo J, Xu C, Cao Y, Fang Z, Wang Q. 2020. Pharmacological mechanisms underlying the neuroprotective effects of Alpinia oxyphylla Miq. on Alzheimer's disease. IJMS. 21(6):2071.
  • Xu N, Shao Y, Ye K, Qu Y, Memet O, He D, Shen J. 2019. Mesenchymal stem cell-derived exosomes attenuate phosgene-induced acute lung injury in rats. Inhal Toxicol. 31(2):52–60.
  • Yazicioglu T, Muhlfeld C, Autilio C, Huang CK, Bar C, Dittrich-Breiholz O, Thum T, Perez-Gil J, Schmiedl A, Brandenberger C. 2020. Aging impairs alveolar epithelial type II cell function in acute lung injury. Am J Physiol Lung Cell Mol Physiol. 319(5):L755–L769.
  • Zhang H, Xu C, Tian Q, Zhang Y, Zhang G, Guan Y, Tong S, Yan J. 2021. Screening and characterization of aldose reductase inhibitors from traditional Chinese medicine based on ultrafiltration-liquid chromatography mass spectrometry and in silico molecular docking. J Ethnopharmacol. 264:113282.
  • Zhao M, Chen Y, Wang C, Xiao W, Chen S, Zhang S, Yang L, Li Y. 2018. Systems pharmacology dissection of multi-scale mechanisms of action of Huo-Xiang-Zheng-Qi formula for the treatment of gastrointestinal diseases. Front Pharmacol. 9:1448.
  • Zhao Z, Miao Y, Pan P, Cheng B, Bai G, Wu H. 2013. Qingfei Xiaoyan Wan alleviates asthma through multi-target network regulation. BMC Complement Altern Med. 13:206.
  • Zheng Y, Li T. 2018. Interleukin-22, a potent target for treatment of non-autoimmune diseases. Hum Vaccin Immunother. 14(12):2811–2819.
  • Zhu N, Hou J, Ma G, Guo S, Zhao C, Chen B. 2020. Co-expression network analysis identifies a gene signature as a predictive biomarker for energy metabolism in osteosarcoma. Cancer Cell Int. 20:259.
  • Zhu N, Hou J. 2020. Exploring the mechanism of action Xianlingubao prescription in the treatment of osteoporosis by network pharmacology. Comput Biol Chem. 85:107240.